Key stages influencing SEND readiness and where challenges typically arise Introduction With SEND now required for U.S. FDA submissions, its role extends beyond dataset creation and directly influences submission quality, review efficiency, and regulatory confidence. However, achieving SEND readiness is often more complex than anticipated. What appears to be a structured, standards-driven process can become challenging in practice particularly across diverse studies, systems,